ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Autoimmunity"

  • Abstract Number: 64 • 2019 ACR/ARP Annual Meeting

    Rab4A Controls mTOR Pathway Activation, Pro-inflammatory Lineage Development, and Disease Pathogenesis in Lupus-prone Mice

    Nick Huang1, Zhiwei Lai 2, Brandon Wyman 2, Thomas Winans 2, Manuel Duarte 2, Joshua Lewis 2, Mark Haas 3, Laurence Morel 4 and Andras Perl 5, 1Upstate Medical University, Syracuse, NY, 2Upstate Medical University, Syracuse, 3Cedars-Sinai Medical Center, Los Angeles, CA, 4University of Florida, Gainesville, FL, 5SUNY Upstate Medical University, Syracuse, NY

    Background/Purpose: Mouse models of SLE have been indispensable tools for studying disease pathogenesis; however, each model only recapitulates limited aspects of lupus. SLE1.2.3. (TC) mice…
  • Abstract Number: 71 • 2019 ACR/ARP Annual Meeting

    Inhibition of Nuclear Pore Export Ameliorates Lupus via Modulation of Plasma Cell Generation and Survival

    Javier Rangel-Moreno1, Maria de la luz Garcia-Hernandez 2, Teresa Owen 3, Jennifer Barnard 3, Bruce Goldman 3, Christopher Ritchlin 2, Douglas Widman 4, Savanna Gornisiewicz 4, Sharon Tamir 4 and Jennifer H Anolik 3, 1University of Rochester Medical center, Rochester, NY, 2Division of Allergy, Immunology and Rheumatology, Center for Musculoskeletal Research, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA, Rochester, NY, 3University of Rochester, Rochester, NY, 4Karyopharm Therapeutics, Newton, MA

    Background/Purpose: A major challenge in lupus is the elimination of autoreactive plasma cells, which amplify inflammation at peripheral sites via deposition of autoantibody-self antigen complexes.…
  • Abstract Number: 531 • 2019 ACR/ARP Annual Meeting

    Efficacy and Safety of Gonadotropin-Releasing Hormone Antagonism in Severe Biologic Refractory Rheumatoid Arthritis

    Anita Kass1, Hans Christian Gulseth 1 and Camilla Zettel 1, 1Betanien Hospital, Skien, Norway

    Background/Purpose: The pathogenesis of rheumatoid arthritis (RA) is unclear, and additional therapeutic approaches are needed. The improvement of RA disease activity during pregnancy, and flares during the…
  • Abstract Number: 706 • 2019 ACR/ARP Annual Meeting

    Neuronal BC RNAs: Systemic Lupus Erythematosus Autoantibodies Cause Dendritic Transport Impairments

    ILHAM MUSLIMOV1, ANNA IACOANGELI 2, TAESUN EOM 3, ANNE RUIZ 3, MADISEN LEE 3, STACY STEPHENSON 3 and Ellen M Ginzler 4, 1SUNY DOWNSTATE MEDICAL CENTER Center, BROOKLYN, NY, 2Tisch MS Research Center of New York, NEW YORK, NY, 3SUNY DOWNSTATE MEDICAL CENTER, BROOKLYN, NY, 4State University of New York Downstate Medical Center, Brooklyn, NY

    Background/Purpose: In systemic lupus erythematosus (SLE), autoantibodies are often directed against nucleic acids or their binding proteins. Regulatory Brain-specific Cytoplasmic (BC) RNAs operate as translational…
  • Abstract Number: 957 • 2019 ACR/ARP Annual Meeting

    Alterations in Cholesterol Homeostasis Regulate Autoimmunity/Age-associated B Cells

    Zhu Chen1, Michela Manni 1, Danny Flores-Castro 1, Tania Pannellini 1 and Alessandra Pernis 2, 1Autoimmunity and Inflammation Program, Hospital for Special Surgery, New York, 21.Autoimmunity and Inflammation Program, Hospital for Special Surgery. 2.David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery. 3.Department of Medicine, Weill Cornell Medical College, Cornell University, New York

    Background/Purpose: Age-associated B cells (ABCs) are a novel B cell subset, which expands with age in non-autoimmune mice but accumulates prematurely in autoimmune-prone strains. ABCs…
  • Abstract Number: 987 • 2019 ACR/ARP Annual Meeting

    Anti-citrullinated Protein Antibodies Induce Subclinical Inflammation, Bone Loss and Pain in Mice

    Akilan Krishnamurthy1, Yogan Kisten 2, Alexandra Circiumaru 3, Katalin Sandor 4, Koji Sakurabas 5, Gustaf Wigerblad 6, Peter Damberg 7, Heidi Wähämaa 3, Patrik Jarvolli 7, Vivianne Malmström 8, Lars Klareskog 9, Camilla I Svensson 10, Juan Jimenez Jimenez Andrade 11, Bence Rethi 3 and Anca Catrina 9, 1Rheumatology unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Solna, Stockholm, 2Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Stockholms Lan, Sweden, 3Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, 4Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden, stockholm, Sweden, 5Rheumatology unit, Department of Medicine, Karolinska University Hospital and Karolinska Institutet, Solna, stockholm, Sweden, 6karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, Stockholm, Sweden, 7Karolinska Institutet, Karolinska Experimental Research and Imaging Centre (KERIC), stockholm, Sweden, stockholm, Sweden, 8Rheumatology Unit, Department of Medicine, Karolinska University Hospital and Institutet, Stockholm, Sweden., Stockholm, Sweden, 9Rheumatology unit Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Stockholm, Sweden, 10Karolinska Institutet, Physiology and Pharmacology, stockholm, Sweden, Stockholm, Sweden, 11Universidad Autónoma de Tamaulipas, Reynosa, Tamaulipas, Mexico, Tamaulipas, Mexico

    Background/Purpose: Autoantibodies against citrullinated proteins (ACPAs) could be associated with bone loss, pain and tenosynovitis prior to disease onset in human rheumatoid arthritis (RA) and…
  • Abstract Number: 1930 • 2019 ACR/ARP Annual Meeting

    Analysis of Lupus Nephritis Gene Expression Reveals Dysregulation of Pathogenic Pathways Activated Within Infiltrating Cells

    Adam Labonte1, Jackson Xu 2, Sarah Heuer 2, Robert Robl 2, Prathyusha Bachali 1, Michelle Catalina 1, Peter Lipsky 3 and Amrie Grammer 4, 1AMPEL Biosolutions and the RILITE Research Institute, Charlottesville, VA, 2AMPEL BioSolutions, Charlottesville, VA, 3AMPEL BioSolutions, LLC, Charlottesville, VA, 4AMPEL BioSolutions and RILITE Research Institute, Charlottesville, VA

    Background/Purpose: LN is a serious complication of SLE that affects about 20-40% of all lupus patients and leads to kidney damage, end-stage renal disease, and…
  • Abstract Number: 2001 • 2019 ACR/ARP Annual Meeting

    Survivin Controls the Transcriptional Activity by Changing the Pattern of Histone H3 Marks on Chromatin

    Karin Andersson 1, Malin Erlandsson 1, Anastasius Damdimopoulos 2, Robin Bremer 1, Maja Jensen 3, Maria-José Garcia-Bonete 3, Gergely Katona 3 and Maria Bokarewa1, 1Department of Rheumatology and Inflammation Research, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden, 2Department of Biosciences and Nutrition, Karolinska Institute, Solna, Sweden, Stockholm, Sweden, 3Department of Chemistry and Molecular Biology, the Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, Gothenburg, Sweden

    Background/Purpose: The oncoprotein survivin coded by the BIRC5 gene was described as an important marker in rheumatoid arthritis (RA). Survivin participates in cell division being…
  • Abstract Number: 2035 • 2019 ACR/ARP Annual Meeting

    Systemic Lupus Erythematosus (SLE) Is Caused by Expanded DOCK8-Positive Autoantibody-Inducing CD4 T (aiCD4 T) Cell

    Shunichi Shiozawa1, Ken Tsumiyama 1, Yumi Miyazaki 2, Keiichi Sakurai 3, Takahiko Horiuchi 4, Motohiro Oribe 5, Takashi Yamane 6, Hidetoshi Kagawa 7 and Kazuko Shiozawa 8, 1Institute for Rheumatic Diseases, Ashiya, Japan, 2Kyushu University Beppu Hospital, Tokyo, Japan, 3Rheumatology and Allergology, St. Marianna University School of Medicine, Tokyo, Japan, 4Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, Beppu, Japan, 5Oribe Rheumatology Clinic, Oita, Japan, 6Department of Rheumatology, Kakogawa Central City Hospital, Kakogawa, Japan, 7Rheumatology, Red Cross Society Himeji Hospital, Himeji, Japan, 8Rheumatic Diseases Center, Hyogo Prefectural Kakogawa Medical Center, Ashiya, Japan

    Background/Purpose: We previously found in reproducible experiments in which the mice not prone to autoimmune disease were immunized repeatedly with antigen that overstimulation of CD4…
  • Abstract Number: 2130 • 2019 ACR/ARP Annual Meeting

    Enrichment of IL-17-producing CD4+ T Cells in Synovial Fluid from Patients with Arthritis After anti-CTLA-4 and anti-PD-1 Combination Therapy

    Sang Kim1, Jean Tayar 1, Maria E. Suárez-Almazor 2, Huifang Lu 1, Yang-Zhi Zhao 1, Zhongshan Liu 3, Emma Rodriguez 1, Sattva Neelapu 1, Jennifer Wang 1, Amishi Shah 1, Nizar Tannir 3, Don Gibbons 3, Guillermo Garcia-Manero 3, Hussein Tawbi 3, Patrick Hwu 1, Andrew Futreal 3, Adi Diab 3 and Roza Nurieva 3, 1MD Anderson Cancer Center, Houston, TX, 2Department of Rheumatology/Clinical Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX , USA., Houston, TX, 3MD Anderson Cancer Center, Houston

    Background/Purpose: Immune checkpoint inhibitors (ICIs) are associated with immune-related adverse events (irAEs), including arthritis (arthritis-irAE). Understanding the pathophysiology of arthritis-irAE is critical to treating it…
  • Abstract Number: 2585 • 2019 ACR/ARP Annual Meeting

    A Comparison of Risk of Ovarian Failure Following Intravenous Cyclophosphamide Therapy in Juvenile versus Adult Systemic Lupus Erythematosus

    shefali sharma1, Hemanth Chinthala 2, siddharth Jain 2, Arghya Chattopadhyay 2, Pooja Bahl 2, Varun Dhir 3, naresh Sachdeva 2 and Surjit Singh 4, 1Dr., Chandigarh, Chandigarh, India, 2Post Graduate Institute of Medical Education and Research, chandigarh, Chandigarh, India, 3Post Graduate Institute of Medical Education and Research, Chandigarh, India, 4Allergy Immunology Unit, Department pf Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India

    Background/Purpose: Premature ovarian failure is a dreaded complication of cyclophosphamide (CYC).  It is related to age of initiation of therapy and the cumulative dose. This…
  • Abstract Number: 2623 • 2019 ACR/ARP Annual Meeting

    Abnormality of Percentages and Absolute Numbers of CD4+ Memory and Regulatory T Subset Cells in ANCA-associated Vasculitis

    Yanlin Wang1, Xiangcong Zhao 2, Chong Gao 3 and Jing Luo 2, 1The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, China (People's Republic), 2the Second Hospital of Shanxi Medical University, Taiyuan, China (People's Republic), 3Brigham and Women’s Hospital, Harvard Medical School, Boston

    Background/Purpose: CD4+ T cell subsets control immune system in check and prevent autoimmunity by keeping a balance among them. However, their levels of blood in ANCA-associated vasculitis (AAV), especially absolute…
  • Abstract Number: 1082 • 2018 ACR/ARHP Annual Meeting

    Peripheral Blood CD11c+ CD21- Age-Associated B Cells (ABCs) in Human Systemic Lupus Erythematosus Are Associated with Innate Type III Interferon and Disease Activity

    Jennifer L. Barnas, Lin Gao, Mary O'Connell, Jennifer Albrecht, Nida Meednu, R. John Looney and Jennifer Anolik, Medicine- Allergy, Immunology and Rheumatology, University of Rochester Medical Center, Rochester, NY

    Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by an interferon-stimulated gene (ISG) signature typically attributed to interferon (IFN)-α. However, ISGs can be induced by other…
  • Abstract Number: 1971 • 2018 ACR/ARHP Annual Meeting

    PLCG2 Variants Influence CVID Susceptibility: Expanding the Spectrum of PLCG2-Associated Immune Dysregulation

    Ann Marie Szymanski1, Kathleen Baysac1, Hannah Marcy1, Elizabeth Baskin1, Joshua Milner2 and Michael Ombrello1, 1Translational Genetics and Genomics Unit, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Bethesda, MD, 2Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD

    Background/Purpose: Immune dysregulation refers to alterations in immune signaling leading to development of autoimmunity, infection and atopic disease. Common variable immunodeficiency (CVID), a prototypic disorder…
  • Abstract Number: 2085 • 2018 ACR/ARHP Annual Meeting

    Response Gene to Complement-32 Promotes Kidney Damage in Immune Complex –Mediated Glomerulonephritis

    Anamaria Talpos-Caia1,2, Vinh Nguyen2,3, Alexandru Tatomir3,4, Sun-sang Sung5, John Papadimitriou6, Sergei Atamas2,3, Irina G. Luzina2,3, Simona Rednic1, Horea Rus3,4 and Violeta Rus2,3, 1Rheumatology, University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania, 2Medicine, Division of Rheumatology and Clinical Immunology, University of Maryland School of Medicine, Baltimore, MD, 3Research Service, Veteran Affairs Medical Center, Baltimore, MD, 4Neurology, University of Maryland School of Medicine, Baltimore, MD, 5Center for Immunity, Inflammation, and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, VA, 6Pathology, University of Maryland School of Medicine, Baltimore, MD

    Background/Purpose: Response Gene to Complement (RGC)-32 is a cell cycle regulator widely expressed in normal tissues including brain, kidney, spleen, thymus, multiple tumors and in…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology